Nephrocare Health Services Gets SEBI Approval for IPO
Dialysis services provider Nephrocare Health Services has received approval from the Securities and Exchange Board of India (SEBI) to launch its initial public offering (IPO).
IPO Structure and Fund Allocation
According to the draft red herring prospectus (DRHP), the Hyderabad-based company’s IPO comprises:
- Offer-for-sale of 1.27 crore equity shares by selling shareholders
- Fresh issue worth ₹353.4 crore
The company plans to utilize the net proceeds from the fresh issue for:
- Capital expenditure of ₹129.1 crore for opening new dialysis clinics across India
- ₹136 crore for prepayment or scheduled repayment of certain borrowings
- Remaining funds for general corporate purposes
Company Background and Global Presence
Incorporated in 2009, NephroPlus (the company’s operational brand) has expanded significantly, recently crossing 500 dialysis centres globally. The company operates across multiple countries including India, the Philippines, Uzbekistan, and Nepal, serving over 33,000 patients annually.
